| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.25 | 0.09 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.09 |